As IFN-α and IFN-β induced PD-L1 and MHC-I expression on tumor cells in TC-1/A9/dIfngr1-originated tumors, we examined the sensitivity of these tumors to anti-PD-L1 therapy (Figure 6). The gene discussed is IFNB1; the disease is neoplasm.